Guided Therapeutics (GTHP) Cash & Equivalents (2010 - 2025)
Guided Therapeutics recorded quarterly Cash & Equivalents of $63000.0 in Q4 2025, down 27.59% quarter-over-quarter from $87000.0 in Q3 2025, and down 83.76% year-over-year from $388000.0 in Q4 2024.
Guided Therapeutics' Cash & Equivalents history runs 16 years deep, the most recent figure standing at $63000.0 for Q4 2025.
- In Q4 2025, Cash & Equivalents fell 83.76% year-over-year to $63000.0; the TTM figure through Dec 2025 stood at $63000.0 (down 83.76% YoY), while the FY2025 annual figure was $63000.0, down 83.76% from the prior year.
- Cash & Equivalents came in at $63000.0 for Q4 2025 at Guided Therapeutics, down from $87000.0 in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $2.7 million in Q3 2022 to a low of $63000.0 in Q4 2025.
- A 5-year average of $790150.0 and a median of $566000.0 in 2021 frame the typical range for Cash & Equivalents.
- Across the five-year window, Cash & Equivalents jumped 5838.1% in 2021 and slumped 83.76% in 2025, its largest moves.
- Guided Therapeutics' Cash & Equivalents stood at $643000.0 in 2021, then soared by 259.72% to $2.3 million in 2022, then plunged by 74.45% to $591000.0 in 2023, then sank by 34.35% to $388000.0 in 2024, then plunged by 83.76% to $63000.0 in 2025.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $63000.0, $87000.0, and $185000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.03 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 63,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 63,000.00 |
| Sep 30, 2025 | 87,000.00 |
| Jun 30, 2025 | 185,000.00 |
| Mar 31, 2025 | 115,000.00 |
| Dec 31, 2024 | 388,000.00 |
| Sep 30, 2024 | 194,000.00 |
| Jun 30, 2024 | 275,000.00 |
| Mar 31, 2024 | 445,000.00 |
| Dec 31, 2023 | 591,000.00 |
| Sep 30, 2023 | 731,000.00 |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.84 Mn |
| Dec 31, 2022 | 2.31 Mn |
| Sep 30, 2022 | 2.70 Mn |
| Jun 30, 2022 | 446,000.00 |
| Mar 31, 2022 | 725,000.00 |
| Dec 31, 2021 | 643,000.00 |
| Sep 30, 2021 | 541,000.00 |
| Jun 30, 2021 | 922,000.00 |
| Mar 31, 2021 | 1.25 Mn |
| Dec 31, 2020 | 182,000.00 |
| Sep 30, 2020 | 581,000.00 |
| Jun 30, 2020 | 763,000.00 |
| Mar 31, 2020 | 21,000.00 |
| Dec 31, 2019 | 899,000.00 |
| Mar 31, 2019 | 6,000.00 |
| Sep 30, 2018 | 70,000.00 |
| Jun 30, 2018 | 41,000.00 |
| Mar 31, 2018 | 76,000.00 |
| Dec 31, 2017 | 1,000.00 |
| Sep 30, 2017 | 74,000.00 |
| Jun 30, 2017 | 8,000.00 |
| Mar 31, 2017 | 1,000.00 |
| Dec 31, 2016 | 14,000.00 |
| Sep 30, 2016 | 4,000.00 |
| Jun 30, 2016 | 22,000.00 |
| Mar 31, 2016 | 56,000.00 |
| Dec 31, 2015 | 35,000.00 |
| Sep 30, 2015 | 172,000.00 |
| Jun 30, 2015 | 1.97 Mn |
| Mar 31, 2015 | 18,000.00 |
| Dec 31, 2014 | 162,000.00 |
| Sep 30, 2014 | 42,000.00 |
| Jun 30, 2014 | 485,000.00 |
| Mar 31, 2014 | 50,000.00 |
| Dec 31, 2013 | 613,000.00 |
| Sep 30, 2013 | 400,000.00 |
| Jun 30, 2013 | 1.98 Mn |
| Mar 31, 2013 | 1.11 Mn |
| Dec 31, 2012 | 1.05 Mn |
| Sep 30, 2012 | 2.61 Mn |
| Jun 30, 2012 | 1.44 Mn |
| Mar 31, 2012 | 1.00 Mn |
| Dec 31, 2011 | 2.20 Mn |
| Sep 30, 2011 | 1.13 Mn |
| Jun 30, 2011 | 2.34 Mn |
| Mar 31, 2011 | 2.31 Mn |
| Dec 31, 2010 | 3.27 Mn |
| Jun 30, 2010 | 373,000.00 |